NOVOCURE LTD reports a Return on Equity (ROE) of -43.94%.

What is NVCR's dividend yield?

NOVOCURE LTD offers a dividend yield of 0.00%.

What is NVCR's Quality Score?

Our AI rates NVCR's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NVCR?

Our AI Timing Score for NVCR is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NVCR belong to?

NOVOCURE LTD is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

NVCR (NASDAQ) Stock Analysis | NOVOCURE LTD

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

NVCR AI Analysis Summary

Our AI summary for NVCR: NOVOCURE LTD (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -43.94%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 56/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NVCR

NOVOCURE LTD

US:NASDAQ STOCK Healthcare >> Medical Devices News 91

USD 14.84

-0.39 (-2.56%) Day Change

Watchlist Portfolio Compare Chart

0.58

D/E

-43.9%

ROE

-18.7%

ROA

0.00%

Div Yield

NOVOCURE LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 14.84 Price -0.39 (-2.56%) Day Change	NEWS SCORE: 91

NVCR, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	14.84
PBV / Sector	5.25 / -101.57
Earning Per Share	-1.24

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	30.39 M GREAT
Average 1W Daily Value	22.90 M GREAT

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

43%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-21.25 / 20.50
NPM Average (%) / Sector	-25.55 / -15.37
NPM Change Average (%) / Sector	20.41 / 7.34 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-18.68 / 39.11
ROA Average (%) / Sector	-15.01 / 5.58
ROA Change Average (%) / Sector	35.70 / 104.50 GREAT
ROE (%) / Sector	-43.94 / -166.42
ROE Average (%) / Sector	-41.77 / -16.93
ROE Change Average (%) / Sector	37.39 / -500.08 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 08:00:15
Symbol	NVCR
Name	NOVOCURE LTD
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	116.45 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,773.47 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Neuhofstrasse 21, Baar, Switzerland, 6340

Phone: 44 15 3475 6700

Website: https://www.novocure.com

Employees: 1,605

Sector: Healthcare >> Medical Devices

Description: NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.